"We observed a 20% reduction in times to approval* - with basic review at 10 days faster than the industry average." - Julia Smith, Director and Group Lead, Global Regulatory Affairs Advertising and Promotion, Takeda

Discover how 2024 Veeva Hero, Julia Smith, PhD at Takeda transitioned from an SOP-driven approach to a systemized one in order to significantly impact content approval times and deliver compliant content to patients faster.

Discover how to streamline content review with a tier-based approach.


*end of 2024

More Customer Stories

GSK: Leveraging GenAI in Commercial Content to Improve MLR Review
Watch Video
Otsuka’s Launch: 90 Days to Personalize Customer Content Using Modular
Read Customer Story
BioMarin on How to Scale Customer-Centric Content for Omnichannel
Read Blog

Interested in learning more about Veeva?